1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  5. Conversations on Cancer
  1. Oncology Center of Excellence

Conversations on Cancer

The FDA Oncology Center of Excellence Conversations on Cancer is a public panel discussion series aimed at fostering dialogue about cancer-related issues, including awareness, prevention, treatment, and regulatory processes. These discussions bring together patients, advocates, academic researchers, and regulatory representatives to discuss topics such as clinical trials, drug approvals, and patient care experiences.

Upcoming Meetings

Conversations on Cancer: Religious Literacy and Spiritual Care for Patients and Caregivers
Date: July 1, 2026
Time: 2:00 pm ET

Background: Research shows that spiritual care for cancer patients remains an unmet need. During this discussion, the panel will explore the differences between religion and spirituality and how increasing religious literacy and spiritual care may impact overall patient care. The discussion will focus on the patient and caregiver experience of their spirituality during cancer care and how religious literacy may improve the care they receive and provide. While the patient will remain central to the discussion, this conversation will also address how providing spiritual care also affects the often-overlooked family and friends who care for cancer patients and the burnout-prone clinicians in today’s healthcare arena, who may or may not consider themselves religious.

Webcast Information:

A free-of-charge webcast of this program can be viewed on July 1, 2026, beginning at 2:00 PM EST on YouTube at: https://www.youtube.com/live/kJtemD4KYMU

FDA also plans to post a webcast of this Conversations on Cancer program on YouTube for on-demand viewing at: https://www.youtube.com/@US_FDA/videos

Conversations on Cancer - Patient First = Project Facilitate
Date: June 10, 2026
Time: 12:00 pm ET

Background: Project Facilitate is a dedicated resource designed to streamline access to investigational therapies for patients facing life-threatening cancers. In this session, the expert panel will explore the evolution of Project Facilitate from its inception to its current role as an essential resource for oncology practitioners nationwide, examining the concrete impact of Project Facilitate through data-driven insights. They will share cases that illustrate both common scenarios and unique challenges, providing practical guidance on how to submit a single-patient IND, highlighting common pitfalls to avoid and best practices for working with pharmaceutical companies, whose agreement is required before FDA review can proceed. Importantly, the panel will address how patient safety is maintained throughout the expanded access process, even when using investigational products whose safety and efficacy profiles are still being established.

Webcast Information: 

A free-of-charge webcast of this program can be viewed on June 10, 2026, beginning at 12:00 PM EST on YouTube at: https://www.youtube.com/live/hkmnRdL4AGE 

FDA also plans to post a webcast of this Conversations on Cancer program on YouTube for on-demand viewing at: https://www.youtube.com/@US_FDA/videos

Past Meetings

Conversations on Cancer – Oncology Nurses – Frontliners in Oncology
Date: May 6, 2026
Time: 3:00 pm-4:00 pm ET

Background: In recognition of National Nurses Week, the FDA Oncology Center of Excellence convened a Conversations on Cancer discussion to spotlight the critical role nurses play as frontline professionals in oncology drug development through their involvement in clinical trials, research coordination, patient care, and education. While their responsibilities extend from direct patient interaction to significant contributions in the research and pharmaceutical industries, their expertise and contributions are often underrepresented and underrecognized in the drug development process. This conversation opens dialogue between frontline nurses and regulatory professionals regarding their roles in cancer treatment and how nursing insights can inform oncology product development, clinical trial participation, and the patient experience.

Webcast Information: 

This program can be viewed on YouTube at: https://www.youtube.com/live/M6f-vqRp3P8.

FDA also plans to post a webcast of this Conversations on Cancer program on YouTube for on-demand viewing at: https://www.youtube.com/@US_FDA/videos



Back to Top